Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2022 08:00 ET | Source: CinRx Pharma

CinDome Pharma announces successful completion of thorough QT study of CIN-102 (deudomperidone) in healthy subjects.

CIN-102, Deudomperidone, is a novel, deuterium-containing, peripherally selective dopamine (D2/D3) receptor antagonist.Study demonstrated that therapeutic and ~5-fold supra-therapeutic concentrations...
September 22, 2021 09:00 ET | Source: CinRx Pharma

CinFina Pharma In-Licenses Obesity Portfolio

Four novel, once-weekly anorectic agents targeting significant weight lossCINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) -- CinFina Pharma, LLC. (“CinFina”) announced today that it has signed an...
September 19, 2019 08:30 ET | Source: CinRx Pharma

CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)

CINCINNATI, Sept. 19, 2019 (GLOBE NEWSWIRE) -- CinDome Pharma, Inc. (“CinDome”), a company whose lead product is deuterated domperidone (CIN-102), today announced that is has enrolled the first...
November 28, 2017 08:00 ET | Source: CinRx Pharma

CinRx Closes $10 Million Series B Financing

CINCINNATI, Nov. 28, 2017 (GLOBE NEWSWIRE) -- CinRx, a biopharmaceutical company with an innovative approach to developing novel therapeutics that address diverse therapeutic areas, announced today...